Gen Surg Cases · vascular
Probeable plantar ulcer with equivocal X-ray — workup, duration, and the surgical threshold
Fellowship clinical-management station on suspected diabetic-foot osteomyelitis with equivocal imaging: probe-plus-X-ray sequencing with likelihood-ratio counselling, MRI-with-biopsy discipline, the 6/3/10-day duration ladder, and surgical-versus-conservative thresholds with margin honesty.
On this page
Study tools
Target exams
Expected management
Combine before scanning. The ulcer probes to bone (JAMA positive LR 6.4) with an ESR of 85 (above the 70 threshold at LR 11) — so add the plain-X-ray result to the probe rather than ordering MRI first: the sequential combination reaches 0.97 sensitivity with 0.92 specificity and likelihood ratios of 12.8 and 0.02, and pooled analysis puts the combination at 0.94 sensitivity with a diagnostic odds ratio of 82 — MRI-comparable, accessible and inexpensive in trained hands.[28][32][31] Note the prevalence honesty aloud: at 12% prevalence the probe's positive value is only 0.57 while its negative value is 0.98 — in this high-risk probe-positive foot the test rules in, and a negative test would have ruled out.[29][30]
Discipline the MRI with biopsy. MRI is the preferred test at 0.90 sensitivity and 0.79 specificity (pooled to 0.96/0.84), and a normal scan at LR 0.14 makes osteomyelitis much less likely — but 29.3% of MRI diagnoses go unconfirmed at biopsy with 12 false positives in the county series, so a positive MRI earns a bone biopsy with culture or histology as gold, plus a radiologist conversation, before committing to resection or weeks of antibiotics.[33][34][28][35]
Shorten antibiotics to the tested floor. Her cellulitis without systemic toxicity and probable osteomyelitis fit the ladder as study regimens: 6 weeks where non-surgical treatment is chosen (65% remission, gut events 15 vs 45%); 3 weeks after adequate debridement (84 vs 73%, noninferior); 10 days for the soft-tissue component after debridement (77 vs 71%) — disclosing the 23-versus-16% new-osteomyelitis tail so surveillance, not duration, carries the residual risk.[36][37][38]
Set the surgical threshold by threat and response. Without life-threat, limb-threat or failure, the non-surgical path holds an 82.3% apparent-remission precedent with oral outpatients and 77% of relapses re-arrested — so admit only the threatened foot for intravenous therapy and operate the failing one.[39] If surgery comes, prioritise foot-sparing conservative procedures (49.1% need no amputation of any part) with S. aureus expected in just over half — and resect to clean margins to shorten antibiotics (21 vs 37 days) while warning that 12-month ulceration, reinfection, amputation and healing do not change either way.[40][41]
Close with classification and cover. Describe the ulcer by SINBAD variables in words — never a lone total, since no system predicts individual outcomes — offload non-removably while it heals, and book lifelong surveillance: recurrence runs 22.1% per person-year.[14][18][4]
References17ShowHide
- [28]Butalia S, et al. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA, 2008.PMID 18285592
- [32]Aragón-Sánchez J, et al. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? Diabet Med, 2011.PMID 21219428
- [31]Calvo-Wright MDM, et al. Is the Combination of Plain X-ray and Probe-to-Bone Test Useful for Diagnosing Diabetic Foot Osteomyelitis? A Systematic Review and Meta-Analysis. J Clin Med, 2023.PMID 37629412
- [29]Lavery LA, et al. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care, 2007.PMID 17259493
- [30]Lam K, et al. Diagnostic Accuracy of Probe to Bone to Detect Osteomyelitis in the Diabetic Foot: A Systematic Review. Clin Infect Dis, 2016.PMID 27369321
- [33]Dinh MT, et al. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis, 2008.PMID 18611152
- [34]Llewellyn A, et al. Imaging for detection of osteomyelitis in people with diabetic foot ulcers: A systematic review and meta-analysis. Eur J Radiol, 2020.PMID 32862106
- [35]La Fontaine J, et al. Magnetic Resonance Imaging of Diabetic Foot Osteomyelitis: Imaging Accuracy in Biopsy-Proven Disease. J Foot Ankle Surg, 2021.PMID 33214100
- [36]Tone A, et al. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care, 2015.PMID 25414157
- [37]Gariani K, et al. Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomized, Noninferiority Pilot Trial. Clin Infect Dis, 2021.PMID 33242083
- [38]Pham TT, et al. Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days. Ann Surg, 2022.PMID 35623048
- [39]Game FL, et al. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia, 2008.PMID 18385975
- [40]Aragón-Sánchez FJ, et al. Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement. Diabetologia, 2008.PMID 18719880
- [41]Lavery LA, et al. Does complete resection of infected bone improve clinical outcomes in patients with diabetic foot osteomyelitis? Int Wound J, 2024.PMID 39375181
- [14]Monteiro-Soares M, et al. Guidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev, 2024.PMID 37179483
- [18]Bus SA, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev, 2024.PMID 37226568
- [4]Fu XL, et al. Global recurrence rates in diabetic foot ulcers: A systematic review and meta-analysis. Diabetes Metab Res Rev, 2019.PMID 30916434